Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
4.040
+0.120 (3.06%)
Jan 20, 2026, 4:00 PM EST - Market closed
ENVB's stock price has decreased by -93.66% in the past year and price targets may not have had time to catch up.
Enveric Biosciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$120.00
Upside
+2,870.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +2,870.30% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $1,800 | Strong Buy | Initiates | $1,800 | +44,454.46% | Jan 30, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $11,250 | Strong Buy | Initiates | $11,250 | +278,365.35% | Jun 1, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy → Hold Downgrades $63,000 → $1,800 | Strong Buy → Hold | Downgrades | $63,000 → $1,800 | +44,454.46% | Mar 8, 2022 |
| Aegis Capital | Aegis Capital | Strong Buy Initiates $63,000 | Strong Buy | Initiates | $63,000 | +1,559,305.94% | Jul 8, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates $54,000 | Strong Buy | Initiates | $54,000 | +1,336,533.66% | Jun 28, 2021 |